---
title: "SAFE, Simple Agreement for Future Equity | MedTech Terms"
description: "Convertible instrument that converts to equity at a future priced round. Plain-English Investment &amp; Finance definition for MedTech teams, with examples and rela"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/safe-note#term",
        "name": "Simple Agreement for Future Equity",
        "alternateName": "SAFE",
        "description": "A SAFE is a financing contract created by Y Combinator in 2013 that gives investors the right to receive shares in a future priced equity round, typically at a discount and/or subject to a valuation cap. Unlike convertible notes, SAFEs carry no interest rate and no maturity date.",
        "url": "https://medtechterms.com/terms/safe-note",
        "termCode": "safe-note",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/safe-note#article",
        "headline": "SAFE, Simple Agreement for Future Equity",
        "description": "Convertible instrument that converts to equity at a future priced round.",
        "url": "https://medtechterms.com/terms/safe-note",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/safe-note"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/safe-note#term"
        },
        "articleSection": "Investment & Finance",
        "inLanguage": "en",
        "keywords": "Simple Agreement for Future Equity, SAFE, Investment & Finance, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "Y Combinator SAFE",
            "url": "https://www.ycombinator.com/documents",
            "publisher": {
              "@type": "Organization",
              "name": "Y Combinator"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "SEC Investor Bulletin: SAFEs",
            "url": "https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_safes",
            "publisher": {
              "@type": "Organization",
              "name": "SEC"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "NVCA Model Documents",
            "url": "https://nvca.org/model-legal-documents/",
            "publisher": {
              "@type": "Organization",
              "name": "NVCA"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/convertible-note#term",
            "name": "Convertible Note",
            "url": "https://medtechterms.com/terms/convertible-note"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/valuation-cap#term",
            "name": "Valuation Cap",
            "url": "https://medtechterms.com/terms/valuation-cap"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Investment & Finance",
            "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Simple Agreement for Future Equity",
            "item": "https://medtechterms.com/terms/safe-note"
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Investment & Finance](/terms?cat=Investment%20%26%20Finance)
6.  /
7.  Simple Agreement for Future Equity

[All terms](/terms)

Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle)SAFE 

# Simple Agreement for Future Equity

Convertible instrument that converts to equity at a future priced round.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

A SAFE is a financing contract created by Y Combinator in 2013 that gives investors the right to receive shares in a future priced equity round, typically at a discount and/or subject to a  [valuation cap](/terms/valuation-cap). Unlike convertible notes, SAFEs carry no interest rate and no maturity date. 

What the regulation says

SAFEs are securities under U.S. federal law and must be issued under an exemption (typically Reg D 506(b) or 506(c)). Form D filings and state blue-sky notices apply. 

## What this means in practice

Early-stage MedTech companies often raise seed capital through SAFEs to defer the valuation discussion until clinical or regulatory milestones (first-in-human, 510(k) submission,  [CE mark](/terms/ce-mark)) materially de-risk the company. Stacking many SAFEs without modeling  [dilution](/terms/dilution) at conversion is a frequent founder mistake. 

## Examples

-   A diagnostics startup raises $2M on a post-money SAFE with a $15M cap to fund an analytical validation study.
-   An implant company uses a discount-only SAFE for a strategic angel before its Series A.

Common pitfalls

-   • Confusing pre-money and post-money SAFEs - post-money SAFEs guarantee the investor's ownership percentage and are far more dilutive at conversion. 
-   • Issuing too many SAFEs with different caps, creating a 'SAFE stack' that surprises founders at the priced round. 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Investment & Finance

Convertible Note

Short-term debt that converts into equity at a future financing round.





](/terms/convertible-note)[

Investment & Finance

Valuation Cap

Maximum company valuation at which a SAFE or note converts to equity.





](/terms/valuation-cap)

### More in Investment & Finance

· Same category 

[

Investment & Finance

409A Valuation

An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options.





](/terms/409a-valuation)[

Investment & Finance

Anti-Dilution Protection

Adjustment that protects investors if the company raises a future round at a lower price.





](/terms/anti-dilution)[

Investment & Finance

Bridge Round

Interim financing between priced rounds, usually convertible.





](/terms/bridge-round)[

Investment & Finance

Burn Rate

Rate at which a company spends cash, typically expressed monthly.





](/terms/burn-rate)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (1)

-   [Startup Lifecycle](/ecosystems/startup-lifecycle)

## Mentioned in recent activity

2 entries 

Trials (2)

[AI-Enabled Mobile App for Safe Eating in Older Adults With Dysphagia ](https://clinicaltrials.gov/study/NCT07654088)

KAM Chi Shan Anna · 2028-01-01 

[An Evaluation of Multisense® to Ensure a Safe Return Home Following High-risk Gastrointestinal Surgery, Compared With Standard Care. ](https://clinicaltrials.gov/study/NCT07552805)

Rhythm Diagnostic Systems · 2026-05-18 

## Latest in MedTech

[View all](/latest?term=safe-note)

Recent regulatory actions, publications, and trials matched to this term. Updated daily.

-   Trial 2026-05-18 
    
    [An Evaluation of Multisense® to Ensure a Safe Return Home Following High-risk Gastrointestinal Surgery, Compared With Standard Care. ](https://clinicaltrials.gov/study/NCT07552805)
    
    Rhythm Diagnostic Systems · NOT\_YET\_RECRUITING
    

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

Y Combinator· 1 SEC· 1 NVCA· 1 

1.  [1 
    
    Y Combinator SAFE
    
    Verified 
    
    Y Combinator · ycombinator.com 
    
    
    
    ](https://www.ycombinator.com/documents)
2.  [2 
    
    SEC Investor Bulletin: SAFEs
    
    Verified 
    
    SEC · sec.gov 
    
    
    
    ](https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_safes)
3.  [3 
    
    NVCA Model Documents
    
    Verified 
    
    NVCA · nvca.org 
    
    
    
    ](https://nvca.org/model-legal-documents/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Diligencing a MedTech cybersecurity posture?

Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Investment & Finance

Acronym

SAFE

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=safe-note)

Learn in 60 seconds

Card Lesson Quiz

Convertible instrument that converts to equity at a future priced round.

-   · Stacking many SAFEs without modeling dilution at conversion is a frequent founder mistake. 
-   · Unlike convertible notes, SAFEs carry no interest rate and no maturity date. 

Remember this

Watch out: Confusing pre-money and post-money SAFEs - post-money SAFEs guarantee the investor's ownership percentage and are far more dilutive at conversion.

Related terms

-   [Convertible Note ](/terms/convertible-note)
-   [Valuation Cap ](/terms/valuation-cap)

You may also need

Auto-suggested from Investment & Finance and shared keywords.

-   [409A Valuation ](/terms/409a-valuation)
-   [Bridge Round ](/terms/bridge-round)
-   [Drag-Along and Tag-Along Rights ](/terms/drag-tag-along)
-   [Liquidity Event ](/terms/liquidity-event)
-   [Capitalization Table(Cap Table) ](/terms/cap-table)
-   [Employee Option Pool ](/terms/option-pool)

[All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)